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a b s t r a c t
The rice C-glycosyltransferase (OsCGT) is one of only a small number of characterised plant C-glycosyl-
transferases (CGT) known. The enzyme C-glucosylates a 2-hydroxyflavanone substrate with UDP-glucose
as the sugar donor to produce C-glucosyl-2-hydroxyflavanones. We tested substrate specificity of the
enzyme, using synthetic 2-hydroxyflavanones, and showed it has the potential to generate known natural
CGFs that have been isolated from rice and also other plants. In addition, we synthesised novel, unnatural
2-hydroxyflavanone substrates to test the B-ring chemical space of substrate accepted by the OsCGT and
demonstrated the OsCGT capacity as a synthetic reagent to generate significant quantities of known and
novel CGFs. Many B-ring analogues are tolerated within a confined steric limit. Finally the OsCGT was
used to generate novel mono-C-glucosyl-2-hydroxyflavanones as putative biosynthetic intermediates
to examine the potential of Desmodium incanum biosynthetic CGTs to produce novel di-C-glyco-
sylflavones, compounds implicated in the allelopathic biological activity of Desmodium against parasitic
weeds from the Striga genus.
 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
In our work to characterise the allelopathic root exudates of the
Desmodium genus and their impact on Striga inhibition in subsis-
tence farming technologies in East Africa (Khan et al., 2002,
2014), we have elucidated a number of C-glycosylflavones (CGFs)
from the active root exudates (Hooper et al., 2015). In addition
their biosynthesis in planta was elucidated and shown to be initi-
ated by a C-glycosyltransferase (CGT) that acts upon 2-hydroxy-
naringenin (3a) using the sugar donor UDP-glucose (Hooper
et al., 2009) (Scheme 1). Subsequent C-glycosylations act upon
the product of this C-glucosylation, 6-C-glucosyl-2-hydroxynarin-
genin (4a), and produce di-C-glycosylflavones (7a–11a) through
the addition of UDP-galactose, UDP-arabinose or UDP-glucose
(Hamilton et al., 2012; Hao et al., 2015). The rice C-glycosyltrans-
ferase (OsCGT) is one of only a small number of characterised plant
C-glycosyltransferases (CGT) known (Brazier-Hicks et al., 2009)
and catalyses the C-glucosylation of 2-hydroxyflavanones with
UDP-glucose as do plants from the Desmodium genus. Recently
the field has expanded to include two characterised CGTs from
Fagopyrum esculentum (UGT708C1, UGT708C2) (Nagatomo et al.,
2014), a bifunctional C- and O-glucosyltransferase from Zea mays
(UGT708A6) (Ferreyra et al., 2013), and one from Glycine max
(UGT708D1) (Hirade et al., 2015), Gentiana triflora (GtUF6CGT1)
(Sasaki et al., 2015) and Mangifera indica (MiUGT13) (Chen et al.,
2015). The CGTs UGT708C1, UGT708C2, UGT708A6, UGT708D1
and GtUF6CGT1 are all capable of producing CGFs although
GtUF6CGT1 does so via a direct flavone glycosylation reaction
and not by C-glucosylation of a 2-hydroxyflavanone. The biological
activities reported for the CGF class of molecules is various, hence
the renewed interest in recent years in this class of chemistry and
the enzymes responsible for their production. CGFs are relevant to
http://dx.doi.org/10.1016/j.phytochem.2016.02.013
0031-9422/ 2016 The Authors. Published by Elsevier Ltd.
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plant ecology, as allelochemicals against Striga (Hooper et al., 2010,
2009), as phytoalexins (McNally et al., 2003), insect antifeedants
(Byrne et al., 1996; Chul-sa et al., 2009), soil-plant interactions
with arbuscular mycorrhizal fungi (Akiyama et al., 2002) and other
pharmacological properties (Talhi and Silva, 2012) such as antiox-
idant activities (Kitta et al., 1992; Kim et al., 2005) and protection
against obesity and cancer (Lee et al., 2010; Nichenametla et al.,
2006). We now aim to exploit the potential of the Oryza sativa, rice
OsCGT in synthetic applications and in biosynthetic studies on the
production of CGFs in planta.
We examined the substrate specificity of the recombinant His-
tagged OsCGT enzyme through a range of synthetic 2-hydroxyfla-
vanones (3a–x), to investigate whether it had the capacity (i) to
generate other natural C-glucosylflavones found in planta, either
from rice or other plants; (ii) to generate novel C-glucosylflavones
to probe the B-ring chemical space tolerated by this enzyme and to
utilise it as a synthetic tool; (iii) to investigate whether sufficient
flexibility exists to build a suitable scaffold biotechnologically for
further functionalization; (iv) to use OsCGT to generate
mono-C-glucosyl-2-hydroxyflavanone intermediates (4) to probe
Scheme 1. Production of di-C-glycosides by the soluble root protein of D. incanum and suitable sugar donor cofactors from the subtrate generated by recombinant OsCGT.
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the capacity of D. incanum to generate novel di-C-glycosylflavones,
allelopathic compounds produced in Desmodium root exudates
that inhibit Striga parasitism of subsistence cereal crops (Hooper
et al., 2015).
2. Results and discussion
2.1. Synthesis of 2-hydroxyflavonone substrates
Novel and nature-identical 2-hydroxyflavanones were synthe-
sised as previously reported according to the synthetic strategy
shown (Scheme 2) (Hamilton et al., 2009). The divergent chemical
synthesis involves preparation of 2,4-dibenzyloxy-6-hydroxyace-
tophenone which is esterified by a range of aromatic acids to gen-
erate 1a–x which undergo a Baker–Venkataraman rearrangement
to the subsequent propanediones 2a–x. These were deprotected
by one of two methods. The first was using 10% Pd on charcoal
under a hydrogen atmosphere after which filtration and purifica-
tion on silica gel furnished the substrate 3a–t. However, some sub-
strates were not stable to this and so were produced by using
platinum dihydroxide under hydrogen, evaporating the solvent
and washing the catalyst with ethanol under nitrogen to obtain
the products 3u–x that were separated from the catalyst using a
centrifuge and therefore not purified before immediate use.
2.2. Sugar substrate specificity
The substrate specificity of OsCGT was assessed by challenging
the enzyme with synthetic 2-hydroxynaringenin (3a) and a range
of commercially available sugar donors. No new products were
found using UDP-glucuronic acid, UDP-galactose, UDP-arabinose
or UDP-N-acetylglucosamine and so OsCGT showed specificity to
UDP-glucose as the sugar donor in its glycosyltransferase activity.
2.3. OsCGT C-Glucosylation of 2-hydroxyflavanones derived from
known natural product structures
Oryza sativa in rice produces CGFs from 2-hydroxynaringenin
(3a) and from 2-hydroxyeriodictyol (3b), which are C-glucosylated
to vitexin 5a, isovitexin 6a, orientin 5b and isoorientin 6b, products
that may be further glycosylated to more complex metabolites
(Brazier-Hicks et al., 2009). Rice also produces 30,50-dimethoxyapi-
genin (tricin) but no C-glucosylated derivatives of that B-ring
structure, only two O-glucosylated derivatives. This may be
because the intermediate 3e is not present or not available for C-
glucosylation. Any late-stage B-ring oxidation of a flavone gener-
ates a substrate that cannot be C-glucosylated as C-glucosylation
must occur before flavone formation. C-glycosylflavonoid plant
natural products derived from the substrates 3c–g and not found
in rice are affinetin (5c) (Trichomanes venosum), isoaffinetin (6c)
(Polygonum affine), scoparin (5d) (Sarothamnus scoparius), isosco-
parin (6d) (Hordeum vulgare), pyrenin (5e) (Gentiana pyrenaica),
isopyrenin (6e) (Gentiana pyrenaica), cytisocise (5f) (Cytisus labur-
num), isocytisocide (6f) (Fortunella margarita), 8-C-glucosylchrysin
(5g) (Scutellaria amoena), 6-C-glucosylchrysin (6g) (Scutellaria
baicalensis) and many more natural products derived from these
parent molecules. We therefore used the appropriate 2-hydrox-
yflavanone precursors 3a–g to test the OsCGT substrate specificity
to 2-hydroxyflavanones with varying hydroxyl and methoxyl
groups that may be present naturally in other plants. The sub-
strates were incubated with OsCGT and UDP-glucose as before
and all of them were efficiently C-glucosylated by the OsCGT
enzyme with good yields (Table 1). The yields were obtained by
HPLC integration of the products at 350 nm, close to the flavone
maximum, and show the enzyme could generate C-glucosyl-2-
hydroxyflavanones 4a–g, if the analogous 2-hydroxyflavanone
were present, which were dehydrated chemically to 5a–5g and
6a–6g (Scheme 3). In order to verify that the products were the
expected 6-C- and 8-C-glucosylflavones, the enzyme reactions
involving substrates 3a, 3b, 3d, 3f, 3gwere scaled up and the prod-
ucts isolated for NMR spectroscopic characterisation. The genera-
tion of milligram quantities shows that in some instances, where
yields are high, the use of OsCGT as a synthetic reagent is feasible.
The 2-hydroxyflavanones known in nature from rice are 3a and 3b,
however, the capacity of a CGT to C-glucosylate other 2-hydrox-
yflavanones that would give rise to CGFs found as natural products
means that this biosynthetic possibility, as well as late stage B-ring
oxidation, cannot be precluded.
2.4. OsCGT C-glucosylation of novel 2-hydroxyflavanones
Compounds 3h–x were prepared to examine further the toler-
ance of the OsCGT to B-ring analogues of its natural substrate
and assays with OsCGT were conducted in the same way as
described above. Substrates 3g and 3o–q show a sequence of
increasing steric bulk of an alkyl group in the R40 position and as
the steric bulk increases, the yield of CGFs drops with a t-butyl
group (3q) implying that this group surpasses the steric constraints
that are acceptable to the enzyme. This is verified by substrates 3a,
3f, 3k, 3l, 3m, 3n which have an increasing alkoxy steric bulk at
R40. This time, as steric bulk increases, so the yield decreases
through the series until the limit is reached between a C3 (3l)
and C6 (3m,n) group. The electronic requirements of the B-ring
were also tested using substrates 3r–3x through the addition of
halogen moieties. Interestingly, all the fluorinated substrates were
Scheme 2. (i) Ac2O, pyridine; (ii) NaH, H2O, BnBr, 99% (2 steps); (iii) TFA, TFAA, 87%; (iv) TiCl4, 76%; (v) EDC, DMAP, ArCO2H, 48–99%; (vi) NaOH, pyridine, 7–70%; (vii) 10%
Pd/C or Pt(OH)2, 19–84%.
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efficiently C-glucosylated, despite having an electron withdrawing
and deactivating effect on the ring which is contrary to the electron
donating and activating natural substrates. Chlorinated and bromi-
nated analogues were not turned over by the OsCGT. As before,
using substrates 3o, 3p, 3r and 3t, where yield were high, products
were isolated from scaling up enzyme assays and the products
characterised by NMR spectroscopy to verify structure. Substrates
3u–3x were designed to produce halogenated CGFs that may be
used to attach biologically active glucosylated flavones to other
biologically active compounds through Pd-catalysed cross-
coupling chemistry. However, these results mean using OsCGT as
a synthetic tool in this respect appears not to be feasible.
2.5. Synthesis of 6- and 8-C-glucosylflavones from synthetic 2-
hydroxyflavanones by D. incanum soluble root proteins
In our previous work demonstrating the biosynthesis of allelo-
pathic C-glycosylflavonoids found in the root exudates of Desmod-
ium spp., we demonstrated C-glucosylation in this genus requires a
2-hydroxyflavonone substrate (Hamilton et al., 2009). We there-
fore challenged the soluble root proteins of D. incanum with the
synthetic 2-hydroxyflavanones to assess whether there are signif-
icant differences in the capacity of D. incanum to C-glucosylate
2-hydroxyflavanones compared to the rice recombinant OsCGT
protein (Table 3). Where standards were not available from the
experiments with OsCGT which allowed NMR characterisation,
the two products were analysed by high cone voltage ESIMS exper-
iments to verify the C-glucosyl link to the flavonoid core through
the loss of 90 and 120 amus (Fig. 1) (Cuyckens and Claeys, 2004)
(Supplementary data). An example of the mass spectrometric anal-
ysis is shown for incubation assays with 3h (30,40-methylenedioxy)
(Fig. 2) and in this case the products are fully characterised as 5h
and 6h. The differences between the two systems are small but rel-
evant. OsCGT cannot C-glucosylate the sterically bulky 3n (t-butyl)
and 3q (phenyl) while D. incanum can, implying a relaxed steric
constraint. However, this is minimal as 3p (hexamethylenoxyl) still
cannot be C-glycosylated by D. incanum as is the case with OsCGT.
Minor differences include the acceptance by OsCGT of a
Table 1
Generation of natural product mono-C-glucosylflavones from 2-hydroxyflavanones and UDP-glucose by the Oryza sativa OsCGT.
UDP-Glu
HCl
O
OOH
HO
R3'
R4'
R5'
O
HO
OH
HO
OH
O
OOH
HO
R3'
R4'
R5'
O
OH
HO OH
OH
3
O
OOH
HO
R3'
R4'
R5'
OH
5 6
R30 R40 R50 8-C-Glucoside
%
6-C-Glucoside
%
3a H OH H 5a; 44* 6a; 53*
3b OH OH H 5b; 43* 6b; 56*
3c OH OH OH 5c; 40 6c; 27
3d OMe OH H 5d; 41* 6d; 53*
3e OMe OH OMe 5e; 69y 6e; 21
3f H OMe H 5f; 44* 6f; 52*
3g H H H 5g; 33* 6g; 47*
* Products characterised by NMR spectroscopy.
y Not pure by NMR spectroscopy.
Scheme 3. Synthesis of glucosylated 2-hydroxyflavanones using OsCGT and dehydration to produce 4 for biosynthetic experiments with Desmodium incanum proteins or 5
and 6 as standards for characterization.
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brominated substrate 3v although at a very low level and 3i
(30,50-hydroxy) which was surprisingly not C-glycosylated by
D. incanum proteins. A significant difference was the ability of
D. incanum proteins to turn over chlorinated substrates which
would allow the potential for generating chlorinated biologically
active synthons for cross-coupling. These results demonstrate that
crude D. incanum soluble protein has a different, though very sim-
ilar capacity to accept novel substrates. These differences may be
due to a single protein having a less sterically hindered substrate
specificity for the substrate B-ring (3n and 3q) along with some
different electronic requirements (3i, 3v, 3w, and 3x) or it may
be due to different C-glycosyltransferases with a combined greater
range of acceptable chemical space for 2-hydroxyflavanones. In
any case, the plant has a greater capacity for producing novel
C-glucoslyflavones than those possible using the single rice recom-
binant OsCGT.
2.6. Synthesis of 6,8-di-C-glycosylflavones using 6-C-glucosyl-2-
hydroxyflavanone substrates created by OsCGT and CGT enzymes from
D. incanum
The results of incubating synthetic 2-hydroxyflavanones with
UDP-glucose and OsCGT (Tables 1 and 2) revealed substrate that
can be used to generate C-glucosyl-2-hydroxyflavanones (4) that
may be themselves substrates for a second glycosylations. In our
work to understand the biosynthesis of di-C-glycosylflavones in
the allelopathic root exudates of D. incanumwe have demonstrated
that the soluble plant enzyme extracts can C-glucosylate,
Fig. 1. Fragmentation of C-hexosides and C-pentosides under high cone voltage ESIMS conditions to generate fragments losses of 60, 90 and 120 amus.
Fig. 2. (A) Ion scan for [MH] 459 showing two new metabolites found in (B) the LCMS ion trace. (C) Molecular ions of two new metabolites and (D) fragmentation under
high cone voltage showing C-link fragments.
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Table 2
Generation of novel mono-C-glucosylfavones from 2-hydroxyflavanones and UDP-glucose by the Oryza sativa OsCGT.
UDP-Glu
HCl
O
OOH
HO
R3'
R4'
R5'
O
HO
OH
HO
OH
O
OOH
HO
R3'
R4'
R5'
O
OH
HO OH
OH
3
O
OOH
HO
R3'
R4'
R5'
OH
5 6
R30 R40 R50 8-C-Glucoside % 6-C-Glucoside %
3h O-CH2– –O H 5h; 44* 6h; 52*
3i OH H OH 5i; 47 6i; 43
3j OH H H 5j; 14 6j; 25
3k H OEt H 5k; 34 6k; 38
3l H O(CH2)3OH H 5l; 17 6l; 27
3m H O(CH2)6OH H 5m; 0 6m; 0
3n H OPh H 5n; 0 6n; 0
3o H Me H 5o; 25* 6o; 33*
3p H Et H 5p; 33* 6p; 41*
3q H t-Bu H 5q; 0 6q; 0
3r F OH H 5r; 42* 6r; 56*
3s H CF3 H 5s; 34 6s; 42
3t H F H 5t; 45* 6t; 47*
3u H Br H 5u; 0 6u; 0
3v Br OH H 5v; 4 6v; 4
3w H Cl H 4w; 0 6w; 0
3x Cl OH H 5x; 0 6x; 0
* Products characterised by NMR spectroscopy.
Table 3
2-Hydroxyflavanones (3) and C-glucosylflvanones (4), generated by OsCGT, introduced to D. incanum soluble root proteins with UDP-sugar donors to generate C-glucosylflavones
(5,6) or di-C-glycosylflavones (7–11). *(Hao et al., 2015).
O
OOH
HO
R3'
R4'
R5'
R3'
R4'
R5'
OHHO
OH O OH
OH O
OH
OH
OH
HO
UDP-glucose
OsCGT
43
R30 R40 R50 6- and 8-C-glucosylflavones (5,6) 6,8-Di-C-hexosylflavones (7,8,9) 6,8-C-Glucosyl-C-arabinosylflavones (10,11)
3a H OH H U⁄ 4a U⁄ U⁄
3b OH OH H U 4b U X
3d OMe OH H U 4d U X
3e OMe OH OMe U 4e X X
3f H OMe H U 4f U U
3g H H H U 4g U Trace
3h O-CH2– –O H U 4h U U
3i OH H OH X 4i X X
3j OH H H U 4j – –
3k H OEt H U 4k U X
3l H O(CH2)3OH H U 4l X X
3m H O(CH2)6OH H X 4m – –
3n H OPh H U 4n – –
3o H Me H U 4o U X
3p H Et H U 4p U X
3q H t-Bu H Trace 4q – –
3r F OH H U⁄ 4r – –
3s H CF3 H U 4s U X
3t H F H U⁄ 4t – –
3v Br OH H X 4v X X
3w H Cl H U 4w – –
3x Cl OH H U 4x – –
78 B. Hao et al. / Phytochemistry 125 (2016) 73–87
C-galactosylate and C-arabinoslyate the mono-C-glucosylfla-
vanones 4a to produce di-C-glycosylflavonones that dehydrate to
the respective flavones (Hamilton et al., 2012; Hao et al., 2015).
We therefore used synthetic 2-hydroxyflavanones that are well
accepted by the OsCGT to generate natural and novel C-glucosyl-
2-hydroxyflavanones (Table 3). By using recombinant OsCGT, these
unstable intermediates can be generated in good yields and purity
without the need for separation from other flavonoids. The incuba-
tion of the substrates with UDP-glucose is expected to give three
products (7–9), rather than one containing two glucose groups,
as the D. incanum soluble enzyme extract is able to isomerise
UDP-glucose to UDP-galactose which is subsequently incorporated
and after dehydration can be fixed in either the C-6 or C-8 position
to give two regiosiomers (Scheme 1) (Hao et al., 2015). The incor-
poration of UDP-arabinose likewise produces two products (10,11),
regioisomers with the C-arabinose in either the 6 or 8 position. In
all cases, where the correct number of novel products was detected
with the correct molecular weight, the fragmentation pattern was
subsequently carried out under high cone voltage ESIMS conditions
to demonstrate that the products are indeed di-C-glycosylflavones.
In the case of C-hexosylflavones, loss of 90 and 120 amus indicate
the correct C-link and with C-arabinosylflavones, loss of 60 and 90
amus is indicative of the correct structure (Fig. 1). The results of
these experiment showed that there was a greater relaxed
specificity for C-glucosylation and C-galactosylation than for
C-arabinosylation. Substrates 4a,b,d,f,g,h,k,o,p,s all produced 3
new metabolites when incubated with UDP-glucose and D.
incanum root protein, deduced to be structures 7, 8 and 9 by ESIMS
mass spectrometry (Supplementary data). In the case of 4b, as the
products are already present in D. incanum and are co-extracted
with the proteins, the labelled sugar moiety UDP-a-D-[UL-13C6]glu-
cose was used and incorporation judged by presence of the labelled
[MH+6] 615 ion with six 13C atoms. The ion trace, low cone volt-
age ESIMS spectrum and fragmented high cone voltage ESIMS
spectra from compounds 7h, 8h, and 9h produced from 4h are
shown (Fig. 3). The selective ion trace at 621 amus (Fig. 3A) shows
three new metabolites with the correct ion ([MH] 621) which
was shown to be the anticipated molecular ion (Fig. 3C). Fragmen-
tation shows sequential losses of 90 ([MH90] 531 and
[MH180] 441} and 120 amus ([MH120] 501 and
[MH240] 381) and combinations of losses ([MH90-120]
411 (Fig. 3D) indicating both sugars must be C-linked to the api-
genin core (Fig. 1). This has previously been shown for 4a where
the three new metabolites produced were characterised through
the NMR characterisation of natural standards as the di-C-glucosy-
lated compound and two C-galactosylated regioisomers 7a, 8a and
9a (Hooper et al., 2015). The substrates that were not incorporated
were 4e and 4i which both possess two oxygen atoms in meta
positions. The more sterically bulky substrate 4l was also not
C-hexosylated. In the case of C-arabinosylation, however, there
Fig. 3. (A) Ion scan for [MH] 621 showing three newmetabolites found in (B) the LCMS ion trace. (C) Molecular ions of three new metabolites and (D) fragmentation under
high cone voltage showing C-link fragments.
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was a distinctly lower tolerance for different B-ring functionality
with products only generated from substrates 4f, 4h and traces
from 4g, all very close in structure to the natural substrate 4a.
These three substrates were incorporated to yield 10f,g,h and
11f,g,h (Supplementary data). Representative data (Fig. 4) reveal
two compounds in the ion trace (Fig. 4B) with ions of 591
(Fig. 4A) which are revealed as molecular ions [MH] 591
(Fig. 4C) and which fragment to give losses of 60 ([MH60]
531, losses of 90 [MH90] 501}, losses of 120
([MH120] 471 and combinations of losses ([MH60-90]
441, [MH60-120] 411 and [MH90-120] 381 (Fig. 4D) indi-
cating both sugars must be C-linked to the apigenin core (Fig. 1).
3. Conclusions
Work by others (Brazier-Hicks et al., 2009) revealed the sub-
strates most suitable for C-glycosylation by the OsCGT enzyme
possessed a 2,4,6-trihydroxylated benzene ring with a pendant
chain likely to be the open form tautomer of a 2-hydroxyflavanone.
They used naturally derived samples of 3a,b,g, a dihydroxychal-
cone, a benzophenone or an ester. Critically, apart from 2-hydrox-
yflavanones which can exist either as open chain or cyclised forms,
only un-cyclised substrates with a 2,4,6-trihydroxy moiety were
C-glucosylated. Similarly, UGT708C1 and UGT708C2 from
F. esculentum will C-glycosylate 20,40,60-trihydroxyacetophenones
and trihydroxydihydrochalcones but not dihydroxyacetophenone
(Nagatomo et al., 2014), though the highly promiscuous MiUGT13
and the crude CGT activity demonstrated by Pueria lobata, which
biosynthesises the C-glucosylisoflavone puerarin, both accept
dihydroxybenzenoid substrates (Chen et al., 2015, 2010). Consis-
tent with this model, we also synthesised 2,40,7-trihydroxyfla-
vanone which does not possess the trihydroxybenzenoid moiety
and this substrate was not C-glucosylated by OsCGT, even though
NMR data showed it existed in the open chain tautomeric form.
The stability and solution availability of the cyclised tautomers of
novel 2-hydroxyflavanones relative to their open chain form may
therefore influence the rate at which the substrates are C-glucosy-
lated. Our NMR characterisation of 2-hydroxyflavanone substrates
(3) often had to be conducted at low temperature (60 C) to
Fig. 4. (A) Ion scan for [MH] 591 showing two new metabolites found in (B) the LCMS ion trace. (C) Molecular ions of two new metabolites and (D) fragmentation under
high cone voltage showing C-link fragments.
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stabilise the cyclised tautomer so preventing tautomeric intercon-
version and allowing structure confirmation. The flexibility of B-
ring analogues being accepted by the rice OsCGT and by active
CGTs in the soluble root proteins of D. incanum is again consistent
with this model as the differences are distal from the open-chain
2,4,6-trihydroxybenzene active site, although analogues must
remain within a steric restraint. As that limit is approached there
is reduced activity of the CGT both in OsCGT and in the active
D. incanum protein mixture. However, the added tolerance of
different chemistries on the B-ring by D. incanum CGTS, in particu-
lar halogen introduction, may allow functionalization of a biotech-
nologically produced scaffold by cross-coupling if recombinant
CGTs can be made from D. incanum.
The rice OsCGT can accept synthetic 2-hydroxyflavanones that
allow it to produce the basic C-glucosylflavonoid natural product
metabolites found in other plants and not previously in rice. In
plants, the generation of functionality on the B-ring may be
through late stage modification, particularly oxidation and
methylation, of CGFs produced from 2-hydroxynaringenin, but
these results reveal the C-glucosylation of functionalised natural
2-hydroxyflavanones is also a possibility. In biosynthetic experi-
ments to generate multiply glycosylated flavones using D. incanum
soluble root proteins, the crude nature of the proteins makes the
quantification of products difficult. However, there is clear toler-
ance on B-ring changes when introducing a second hexose that is
not seen in experiments with UDP-arabinose. We suggest that this
is due to a different enzyme controlling C-arabinosylation as com-
pared with C-hexosylation which may be carried out by one CGT
that can perform both C-glucosylation and C-galactosylation or
by separate enzymes. Using this knowledge the biotechnological
production of novel metabolites in vitro or in the field by trans-
genic plants may be pursued.
The high yields of products in our un-optimised reaction condi-
tions show that as a synthetic reagent, the rice OsCGT has the
potential to generate a class of compounds to which many biolog-
ical activities have been attributed in addition to the activity
against parasitic weeds from the Striga genus. A recent study has
demonstrated this potential by optimising one such chemical reac-
tion. The dihydrochalcone phloretin was 30-C-b-D-glucosylated to
nothofagin using OsCGT, in situ production of UDP-glucose and
with b-cyclodextrin complexation to increase substrate availability
(Bungaruang et al., 2015). Alternative methods to synthesise CGFs
synthetically have relied on two approaches. One strategy is heav-
ily reliant on protection group chemistry, with multiply protected
activated sugar donors reacting with protected electron rich aro-
matic moieties. It requires many chemical steps and often suffers
low yields due to the requirement for O-glycosylation followed
by a 1,2-Fries shift to form the C-glycosidic link (Kumazawa
et al., 1995, 2001; Mahliing et al., 1995; Sato et al., 2006a; Furuta
et al., 2009). The other strategy shows greater potential and relies
on Lewis acid catalysed glycosylations (Sc(OTf)3, Yb(OTf)3 or Pr
(OTf)3) of an electron rich aromatic moiety with the unprotected
glycoside, but which must be subsequently converted to the
desired flavonoid using protection chemistry (Sato et al., 2004,
2006b; Sato and Koide, 2010; Santos et al., 2013). Within this
framework, the rice OsCGT or other recombinant C-glycosyltrans-
ferase enzymes also have the potential to contribute to synthetic
strategies.
4. Experimental
General experimental procedures. Electrospray ionisation mass
spectra (ESIMS) were recorded in negative ionisation mode using
the Micromass Quattro Ultima. LCMS analysis was performed on
the Micromass Quattro Ultima bench top triple quadrupole mass
spectrometer attached to Waters Acquity UPLC system (Ultra Per-
formance Liquid Chromatography).
4.1. Synthesis of 2-hydroxyflavanones 3a–x
4.1.1. Synthesis of esters 1a–1x
2,4-Dibenzyloxy-6-hydroxyacetophenone (1.0 g, 2.87 mmol)
was dissolved in 30 mL dry CH2Cl2 along with the selected aro-
matic acid (1.1 eq., 3.16 mmol), 4-dimethylaminopyridine
(0.5 eq., 176 mg) and the coupling agent N-(3-dimethylamino-
propyl)-N0-ethylcarbodiimide hydrochloride (1.25 eq., 689 mg).
The mixture was refluxed overnight, concentrated in vacuo and
purified by column chromatography using 20–50% ethyl acetate
in petroleum ether to yield a viscous oil or waxy solid, 1a (87%),
1b (53%), 1c (49%), 1d (92%), 1e (76%), 1f (67%), 1g (48%), 1h
(69%), 1i (63%), 1j (81%), 1k (67%), 1l (51%), 1n (71%), 1o (80%),
1p (98%), 1q (40%), 1r (68%), 1s (42%), 1t (89%), 1u (99%), 1v
(65%), 1w (89%), 1x (76%).
4.1.2. Synthesis or propanediones 2a–2x
The product of the above reaction was dissolved in pyridine
(15 mL) with 1.0 g of dry, powdered KOH, prepared by powdering
it under ether and drying overnight at 60 C. The mixture was
heated under nitrogen at 85 C for 1 h, cooled in ice, quenched with
acetic acid (6 mL), and the product extracted from water with
dichloromethane. The dichloromethane was washed with HCl
1 M, brine, dried (MgSO4), filtered and the solvent evaporated in
vacuo. The crude residue was crystallised from hot dichloro-
methane by the addition of petroleum ether to yield yellow or
orange crystals of the propanedione. 2a (76%), 2b (50%), 2c (37%),
2d (25%), 2e (50%), 2f (11%), 2g (21%), 2h (34%), 2i (29%), 2j
(33%), 2k (31%), 2l (44%), 2m (70%), 2n (19%), 2o (31%), 2p (20%),
2q (39%), 2r (45%), 2s (9%), 2t (29%), 2u (15%), 2v (7%), 2w (29%),
2x (17%).
4.1.3. Synthesis of 2-hydroxyflavanones 3a–3t
100–300 mg of the propanedione was dissolved in a mixture
containing equal volumes of MeOH and THF (10–30 mL). 20% by
weight of 10% Pd/C was added to the solution which was stirred
under H2 and monitored by TLC. When the reaction was complete,
the solution was filtered, the catalyst washed with acetone and the
organic solvent concentrated in vacuo before column chromatogra-
phy in EtOAc/petroleum ether. The purified product was weighed
and portioned into glass ampoules which were sealed and kept
at 20 C before use. In the case of 3u–3x, the catalyst used was
a very small spatula of Pt(OH)2 and when the reaction was com-
plete by TLC, the solution was placed under nitrogen, the solvent
concentrated in vacuo, the residue re-suspended in the volume of
EtOH required to give a theoretical 20 mM solution of substrate,
and the suspension was centrifuged. Decanting of the supernatant
under nitrogen provided the substrate solution that was immedi-
ately used in enzyme assays.
3a 87%; 1H NMR (500 MHz, (CD3)2CO, 213 K) 12.20 (1H, s, 5-
OH), 10.30 (1H, s, 7-OH), 9.27 (1H, s, 40-0H), 7.56 (2H, d,
J = 8.5 Hz, 20,60-H), 7.00 (1H, s, 2-OH), 6.91 (2H, d, J = 8.4 Hz, 30,50-
H), 5.98 (2H, m, 6,8-H), 3.29 (1H, dd, J = 2.8, 16 9 Hz, H-3a), 2.80
(1H, d, J = 16.9 Hz, 3-Hb); 13C NMR (125 MHz, (CD3)2CO, 213 K)
196.3, 166.7, 164.2, 161.1, 158.1, 134.1, 127.6 (2C), 115.1 (2C),
102.7, 102.3, 96.4, 96.1, 49.2.
3b 60%; 1H NMR (500 MHz, (CD3)2CO, 221 K) 12.18 (1H, s, 5-
OH), 10.41 (1H, s, 7-OH), 8.87 (1H, s, 40-OH), 8.83 (1H, s, 30OH),
7.17 (1H, s, 2-OH), 7.03 (1H, d, J = 8.1 Hz, 20-H), 6.87–6.85 (2H, m,
50,60-H), 5.98 (1H, m, 6-H), 5.97 (1H, s, 8-H), 3.11 (1H, dd, J = 11.0
Hz, H-3a), 2.78 (1H, d, J = 17.3 Hz, 3-Hb); 13C NMR (125 MHz,
(CD3)2CO, 221 K) 195.9, 166.4, 163.8, 160.7, 145.5, 144.7, 134.3,
116.7, 114.6, 112.8, 102.2, 101.9, 96.0, 95.7, 48.9.
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3c 19%; 1H NMR (500 MHz, (CD3)2CO, 221 K) 12.18 (1H, s,
5-OH), 10.24 (1H, s, 7-OH), 8.68 (2H, s, 30,50-0H), 8.20 (1H, s,
40-OH), 6.77 (1H, s, 2-OH), 6.73 (2H, s, 20,60-H), 5.98 (1H, m, 6-H),
5.97 (1H, s, 8-H), 3.22 (1H, dd, J = 2.7, 17.0 Hz, H-3a), 2.75 (1H, d,
J = 16.9 Hz, 3-Hb); 13C NMR (125 MHz, (CD3)2CO, 221 K) 195.9,
166.3, 163.8, 160.7, 145.2 (2C), 133.6, 133.0, 104.5 (2C), 102.2,
101.9, 96.0, 95.7, 48.9.
3d 49%; 1H NMR (500 MHz, (CD3)2CO, 220 K) 12.20 (1H, s,
5-OH), 10.28 (1H, s, 7-OH), 8.54 (2H, s, 40-0H), 7.31 (1H, d,
J = 2.0 Hz, 20-H), 7.18 (1H, dd, J = 2.0, 8.0 Hz, 60H), 6.94 (1H, s,
2-OH), 6.89 (1H, d, J = 8.0 Hz, 50-H), 2-OH), 5.99–5.98 (2H, m,
6,8-H), 3.86 (3H, s, OMe), 3.31 (1H, dd, J = 2.8, 16.9 Hz, H-3a),
2.82 (1H, d, J = 16.9 Hz, 3-Hb); 13C NMR (125 MHz, (CD3)2CO,
220 K) 195.9, 166.4, 163.8, 160.7, 146.9, 146.7, 134.0, 117.9,
114.3, 108.7, 102.3, 101.9, 96.0, 95.7, 55.0, 48.9.
3e 33%; 1H NMR (500 MHz, (CD3)2CO, 220 K) 12.20 (1H, s,
5-OH), 10.41 (1H, s, 7-OH), 8.17 (1H, s, 40-0H), 7.01 (2H, s, 20,60-
H), 6.96 (1H, s, 2-OH), 6.00–5.98 (2H, m, 6,8-H), 3.84 (6H, s, 30,50-
OMe), 3.33 (1H, d, J = 17.0 Hz, H-3a), 2.81 (1H, d, J = 17.0 Hz,
3-Hb); 13C NMR (125 MHz, (CD3)2CO, 220 K) 195.8, 166.5, 163.8,
160.7, 147.1 (2C), 135.3, 132.9, 102.4, 102.1 (2C), 101.8, 96.1,
95.8, 55.3 (2C), 48.8.
3f 52%; 1H NMR (500 MHz, (CD3)2CO, 222 K) 12.18 (1H, s, 5-OH),
10.21 (1H, s, 7-OH), 7.66 (2H, d, J = 8.7 Hz, 20,60-H), 7.02 (1H, d,
J = 8.8 Hz, 30,50-H), 6.94 (1H, s, 2-OH), 6.00 (1H, d, J = 1.8 Hz, 6-H),
5.98 (1H, d, J = 1.8 Hz, 8-H), 3.83 (3H, s, 40-OMe), 3.29 (1H, d,
J = 16.9 Hz, H-3a), 2.83 (1H, d, J = 17.0 Hz, 3-Hb); 13C NMR
(125 MHz, (CD3)2CO, 220 K) 195.8, 166.4, 163.8, 160.6, 159.8,
134.7, 127.0 (2C), 113.3 (2C), 102.2, 101.9, 96.0, 95.7, 54.8, 48.7.
3g 65%; 1H NMR (500 MHz, (CD3)2CO, 292 K) 12.08 (1H, s,
5-OH), 9.70 (1H, s, 7-OH), 7.75 (2H, d, J = 7.0 Hz 20,60-H), 7.47
(2H, t, J = 7.2 Hz, 30,50-H), 7.42 (1H, t, J = 7.0 Hz, 40-H), 6.56 (1H, s,
2-OH), 6.05 (1H, br s, 60-H), 6.01 (1H, d, J = 1.6 Hz, 8-H), 3.24 (1H,
d, J = 16.8 Hz, H-3a), 2.92 (1H, d, J = 16.9 Hz, 3-Hb); 13C NMR
(125 MHz, (CD3)2CO, 293 K) 195.1, 166.4, 164.0, 160.6, 142.7,
128.7, 128.5 (2C), 125.4 (2C), 102.1, 101.9, 96.1, 96.0, 48.6.
3h 76%; 1H NMR (500 MHz, (CD3)2CO, 220 K) 12.16 (1H, s,
5-OH), 10.41 (1H, s, 7-OH), 7.24 (1H, s, 20-H), 7.23 (1H, d,
J = 7.9 Hz, 50-H), 6.96 (1H, dd, J = 1.5, 7.6 Hz, 60-H), 6.11 (2H, s,
OCH2O), 6.00–5.98 (2H, m, 6,8-H), 5.76 (1H, d, J = 3.1 Hz, 2-OH),
3.27 (1H, dd, J = 3.3, 17.2 Hz, H-3a), 2.83 (1H, d, J = 16.8 Hz, 3-
Hb); 13C NMR (125 MHz, (CD3)2CO, 220 K) 195.7, 166.5, 163.8,
160.5, 147.9, 147.6, 136.8, 119.1, 107.7, 106.4, 102.1, 101.8,
101.7, 96.0, 95.8, 48.6.
3i 70%; 1H NMR (500 MHz, (CD3)2CO, 221 K) 12.16 (1H, s, 5-OH),
10.30 (1H, s, 7-OH), 9.05 (2H, s, 30,50-0H), 6.88 (1H, s, 2-OH), 6.68
(2H, d, J = 2.5 Hz, 20,60-H), 6.37 (1H, t, J = 2.1 Hz, 40-H), 6.00 (1H, d,
J = 2.1 Hz, 6-H), 5.98 (1H, d, J = 2.1 Hz, 8-H), 3.24 (1H, dd, J = 2.6,
16.9 Hz, H-3a), 2.79 (1H, d, J = 16.9 Hz, 3-Hb); 13C NMR
(125 MHz, (CD3)2CO, 221 K) 195.6, 166.4, 163.8, 160.5, 158.5
(2C), 145.1, 104.0 (2C), 102.4, 102.0, 101.8, 96.0, 95.8, 48.5.
3j 35%; 1H NMR (500 MHz, (CD3)2CO, 292 K) 12.06 (1H, s, 5-OH),
9.75 (1H, s, 7-OH), 8.62 (1H, s, 40-0H), 7.28 (1H, t, J = 7.9 Hz, 50-H),
7.21–7.17 (2H, m, 20,60-H), 6.88 (1H, dd, J = 2.4, 8.0 Hz, 40-H), 6.51
(1H, d, J = 1.9 Hz, 2-OH), 6.03 (1H, d, J = 2.1 Hz, 6-H), 5.99 (1H, d,
J = 2.2 Hz, 8-H), 3.21 (1H, dd, J = 2.1, 16 9 Hz, H-3a), 2.88 (1H, d,
J = 16.9 Hz, 3-Hb); 13C NMR (125 MHz, (CD3)2CO, 213 K) 195.2,
166.4, 163.9, 160.6, 157.4, 144.3, 129.4, 116.5, 115.5, 112.5,
102.1, 101.8, 96.0, 96.0, 48.6.
3k 82%; 1H NMR (500 MHz, (CD3)2CO, 220 K) 12.18 (1H, s,
5-OH), 10.52 (1H, s, 7-OH), 7.63 (2H, d, J = 8.7 Hz, 20,60-H), 7.04
(2H, d, J = 8.8 Hz, 30,50-H), 6.99 (1H, s, 2-OH), 6.00 (1H, s, 6-H),
5.99 (1H, s, 8-H), 4.09 (2H, q, J = 7.0 Hz, CH2O), 3.26 (1H, d,
J = 16.9 Hz, H-3a), 2.85 (1H, d, J = 16.9 Hz, 3-Hb), 1.39 (3H, t,
J = 7.0 Hz, CH3); 13C NMR (125 MHz, (CD3)2CO, 293 K) 195.4,
166.4, 163.9, 160.7, 159.3, 134.8, 126.8 (2C), 113..9 (2C), 102.1,
101.9, 96.0, 95.9, 63.2, 48.7, 14.2.
3l 75%; 1H NMR (500 MHz, (CD3)2CO, 222 K) 12.18 (1H, s, 5-OH),
10.29 (1H, s, 7-OH), 7.64 (2H, d, J = 8.6 Hz, 20,60-H), 7.01 (2H, d,
J = 8.6 Hz, 30,50-H), 7.00 (1H, s, 2-OH), 6.01 (1H, s, 6-H), 5.99 (1H, d,
J = 1.7 Hz, 8-H), 4.08 (2H, t, J = 6.0 Hz, CH2OAr), 3.74 (2H, q,
J = 5.5 Hz, CH2OH), 3.26 (1H, dd, J = 2.6, 16.9 Hz, H-3a), 2.83 (1H, d,
J = 16.9 Hz, 3-Hb), 1.96 (2H, qu, J = 6.0 Hz, CH2); 13C NMR
(125 MHz, (CD3)2CO, 220 K) 195.8, 166.4, 163.8, 160.6, 159.3,
134.6, 127.0 (2C), 113.7 (2C), 102.2, 101.9, 96.0, 95.8, 64.1, 57.7,
48.8, 32.1.
3m 44%; 1H NMR (500 MHz, (CD3)2CO, 298 K) 12.07 (1H, s, 5-
OH), 9.60 (1H, s, 7-OH), 7.63 (2H, d, J = 8.8 Hz, 20,60-H), 6.99 (2H, d,
J = 8.6 Hz, 30,50-H), 6.44 (1H, s, 2-OH), 6.02–5.99 (2H, m, 6,8-H),
4.05 (2H, t, J = 6.4 Hz, CH2OAr), 3.56 (2H, t, J = 6.5 Hz, CH2OH), 3.21
(1H, d, J = 16.9 Hz, H-3a), 2.89 (1H, d, J = 16.9 Hz, 3-Hb), 1.80 (2H,
m, CH2), 1.58–1.55 (6H, m, 3CH2); 13C NMR (125 MHz, (CD3)2CO,
298 K) 195.3, 166.4, 163.9, 160.7, 159.5, 134.7, 126.8 (2C), 114.0
(2C), 102.1, 102.0, 96.0, 95.9, 67.7, 61.5, 48.8, 32.8, 28.5, 25.8, 25.6.
3n 50%; 1HNMR (500 MHz, (CD3)2CO, 294 K) 12.07 (1H, s, 5-OH),
9.60 (1H, s, 7-OH), 7.75 (2H, d, J = 8.7 Hz, 20,60-H), 7.43 (2H, t,
J = 8.2 Hz, Ph), 7.19 (1H, t, J = 7.4 Hz, Ph), 7.07 (4H, d, J = 8.7 Hz,
30,50-H, Ph), 6.55 (1H, s, 2-OH), 6.04 (1H, d, J = 2.0 Hz, 6-H), 6.01
(1H, d, J = 2.0 Hz, 8-H), 3.26 (1H, d, J = 16.9 Hz, H-3a), 2.93 (1H, d,
J = 16.8 Hz, 3-Hb); 13C NMR (125 MHz, (CD3)2CO, 293 K) 195.1,
166.4, 164.0, 160.5, 157.8, 156.9, 137.6, 130.0 (2C), 127.3 (2C),
123.8, 119.1 (2C), 118.0 (2C), 102.1, 101.8, 96.0, 96.0, 48.7.
3o 90%; 1H NMR (500 MHz, (CD3)2CO, 292 K) 12.07 (1H, s, 5-OH),
9.60 (1H, s, 7-OH), 7.61 (2H, d, J = 8.2 Hz, 20,60-H), 7.27 (2H, d,
J = 8.0 Hz, 30,50-H), 6.48 (1H, s, 2-OH), 6.03 (1H, d, J = 1.9 Hz, 6-H),
5.99 (1H, d, J = 2.0 Hz, 8-H), 3.22 (1H, d, J = 16.9 Hz, H-3a), 2.90
(1H, d, J = 16.9 Hz, 3-Hb), 2.37 (3H, s, Me); 13C NMR (125 MHz,
(CD3)2CO, 292 K) 195.2, 166.3, 163.9, 160.7, 139.9, 138.3, 128.8
(2C), 125.4 (2C), 102.1, 102.0, 96.0, 95.9, 48.7, 20.2.
3p 73%; 1H NMR (500 MHz, (CD3)2CO, 293 K) 12.08 (1H, s,
5-OH), 9.65 (1H, s, 7-OH), 7.64 (2H, d, J = 8.1 Hz, 20,60-H), 7.30
(2H, d, J = 8.1 Hz, 30,50-H), 6.48 (1H, s, 2-OH), 6.04 (1H, d,
J = 1.9 Hz, 6-H), 6.01 (1H, d, J = 2.0 Hz, 8-H), 3.23 (1H, d,
J = 16.9 Hz, H-3a), 2.91 (1H, d, J = 16.9 Hz, 3-Hb), 2.69 (2H, q,
J = 7.6 Hz, ArCH2), 1.24 (3H, t, J = 7.6 Hz, Me); 13C NMR (125 MHz,
(CD3)2CO, 293 K) 195.2, 166.4, 163.9, 160.7, 144.8, 140.1, 127.7
(2C), 125.5 (2C), 102.1, 102.0, 96.0, 96.0, 48.7, 28.2, 15.2.
3q 51%; 1H NMR (500 MHz, (CD3)2CO, 220 K) 12.18 (1H, s,
5-OH), 10.31 (1H, s, 7-OH), 7.66 (2H, d, J = 8.3 Hz, 20,60-H), 7.53
(2H, d, J = 8.3 Hz, 30,50-H), 6.96 (1H, s, 2-OH), 6.00 (1H, s, 6-H),
5.99 (1H, d, J = 2.0 Hz, 8-H), 3.31 (1H, dd, J = 2.6, 16.9 Hz, H-3a),
2.85 (1H, d, J = 17.0 Hz, 3-Hb), 1.32 (9H, s, (CH3)3); 13C NMR
(125 MHz, (CD3)2CO, 221 K) 195.7, 166.4, 163.8, 160.6, 151.4,
139.8, 125.4 (2C), 125.3 (2C), 102.2, 101.9, 96.0, 95.8, 48.5, 34.4,
30.7 (3C).
3r 82%; 1H NMR (500 MHz, (CD3)2CO, 221 K) 12.16 (1H, s,
5-OH), 10.38 (1H, s, 7-OH), 9.67 (1H, s, 40OH), 7.49 (1H, dd,
J = 2.0, 12.2 Hz, 20-H), 7.39 (1H, dd, J = 1.6, 8.4 Hz, 60-H), 7.08 (1H,
t, J = 8.7 Hz, 50-H), 7.07 (1H, d, J = 2.6 Hz, 2-OH), 6.01 (1H, d,
J = 2.0 Hz, 6-H), 5.99 (1H, d, J = 2.1 Hz, 8-H), 3.28 (1H, dd,
J = 16.9 Hz, H-3a), 2.85 (1H, d, J = 16.9 Hz, 3-Hb); 13C NMR
(125 MHz, (CD3)2CO, 236 K) 195.5, 166.4, 163.8, 160.4, 150.6 (d,
J = 239 Hz), 139.8 (d, J = 5 Hz), 122.0 (d, J = 3 Hz), 117. 2, 113.8 (d,
J = 20 Hz), 101.9, 101.5, 96.0, 95.9, 48.5.
3s 84%; 1H NMR (500 MHz, (CD3)2CO, 221 K) 12.92 (1H, s,
5-OH), 11.18 (1H, s, 7-OH), 8.78 (2H, d, J = 8.1 Hz, 20,60-H), 7.69
(2H, d, J = 8.3 Hz, 30,50-H), 8.10 (1H, s, 2-OH), 6.83 (1H, d,
J = 1.5 Hz, 6-H), 6.80 (1H, d, J = 1.7 Hz, 8-H), 4.13 (1H, d,
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J = 16.9 Hz, H-3a), 2.85 (1H, d, J = 16.9 Hz, 3-Hb); 13C NMR
(125 MHz, (CD3)2CO, 294 K) 194.5, 166.5, 163.9, 160.2, 146.8,
130.2 (q, J = 32 Hz), 126.5 (2C), 125.3 (2C, q, J = 4 Hz), 124.3 (2C,
q, J = 278 Hz), 102.0, 101.3, 96.1 (2C), 48.3.
3t 48%; 1H NMR (500 MHz, (CD3)2CO, 293 K) 12.05 (1H, s,
5-OH), 9.73 (1H, s, 7-OH), 7.79 (2H, dd, J = 7.5, 8.8 Hz, 20,60-H),
7.22 (2H, t, J = 8.8 Hz, 30,50-H), 6.66 (1H, s, 2-OH), 6.04 (1H, d,
J = 2.1 Hz, 6-H), 6.01 (1H, d, J = 2.1 Hz, 8-H), 3.24 (1H, d,
J = 16.9 Hz, H-3a), 2.92 (1H, d, J = 17.0 Hz, 3-Hb); 13C NMR
(125 MHz, (CD3)2CO, 294 K) 194.9, 166.4, 163.9, 162.7 (d,
J = 246 Hz), 160.4, 139.0 (d, J = 3 Hz), 127.8 (2C, d, J = 9 Hz), 114.9
(2C, d, J = 21 Hz), 102.0, 101.6, 96.1 (2C), 48.6.
4.2. Generation of 6- and 8-C-glucosylflavones from 3 using
recombinant OsCGT
2-Hydroxyflavanone 3 (40 lL of a 20 mmol solution) in ethanol
was added to 1 mg of UDP-glucose dissolved in 40 lL buffer with
50 lg recombinant OsCGT (Hamilton et al., 2012) dissolved in
200 ll 100 mM HEPES pH 7.5 buffer and incubated at 30 C
overnight. The reaction was terminated by addition of 1 M HCl
(250 lL) and the products isolated on a semi-preparative HPLC
column, ACEQ C-18 column (250 mm  10 mm, 5 lm), using the
analytical method at 4 mL/min (see 4.7), to yield 6- and 8-C-gluco-
sylflavones that were characterised by NMR spectroscopy.
4.2.1. 8-C-Glucosylapigenin (vitexin) 5a
UV (kmax MeOH/H2O) 271, 349 nm. 1H NMR (500 MHz,
d6-DMSO, 300 K) d 7.96 (2H, J = 8.4 Hz, H20, H60), 6.91 (2H, d,
J = 8.5 Hz, H30, H50), 6.63 (1H, s, H3), 6.15 (1H, s, H6), 8-C-b-Glu
4.70 (1H, d, J = 9.8 Hz, H100), 3.89 (1H, t, J = 9.0 Hz, H200), 3.76 (1H,
d, J = 11.4, H6a00), 3.55 (1H, dd, J = 5.7, 11.7 Hz, H6b00), 3.39 (1H, t,
9.3 Hz, H300), 3.31 (1H, t, J = 8.5 Hz, H400), 3.28 (1H, m, H500). 13C
NMR (125 MHz, d4-MeOD, 350 K) 181.6 (C4), 164.2 (C2), 164.0
(C7), 162.2 (C40), 161.1(C5), 156.9 (C9), 129.3 (C20, C60), 122.5
(C10), 116.7 (C30, C50), 105.7 (C8), 103.6 (C10), 103.0 (C3), 100.1
(C6). 6-C-b-Glu 74.8 (C100), 72.2 (C200), 79.8 (C300), 71.6 (C400), 82.6
(C500), 62.4 (C600). ESIMS m/z (CV = 150, rel. int.): 431 [MH]
(57), 341 [MH90] (11), 311 [MH120] (100).
4.2.2. 6-C-Glucosylapigenin (isovitexin) 6a
UV (kmax MeOH/H2O) 271, 349 nm. 1H NMR (500 MHz,
d4-MeOD, 330 K) d 7.79 (2H, J = 8.7 Hz, H20, H60), 6.93 (2H, d,
J = 8.5 Hz, H30, H50), 6.57 (1H, s, H3), 6.49 (1H, s, H8), 8-C-b-Glu
4.94 (1H, d, J = 9.9 Hz, H100), 4.13 (1H, t, J = 9.2 Hz, H200), 3.91 (1H,
d, J = 11.8, H6a00), 3.79 (1H, dd, J = 5.1, 12.1 Hz, H6b00), 3.55–3.47
(2H, m, H300, H400), 3.33 (1H, m, H500). 13C NMR (125 MHz, d4-MeOD,
330 K) 182.5 (C4), 164.8 (C2), 163.1 (C7), 161.1 (C40), 160.5(C5),
157.2 (C9), 127.8 (C20, C60), 121.9 (C10), 115.6 (C30, C50), 107.8
(C8), 103.9 (C10), 102.6 (C3), 94.1 (C8). 81.0 (C500), 78.7 (C300),
74.0 (C100), 71.4 (C200), 70.4 (C400), 61.5 (C600). ESIMS m/z (CV = 150,
rel. int.): 431 [MH] (57), 341 [MH90] (11), 311
[MH120] (100).
4.2.3. 8-C-Glucosylluteolin (orientin) 5b
UV (kmax MeOH/H2O) 298, 349 nm. 1H NMR (500 MHz,
d4-MeOD, 350 K) d 7.51 (1H, br s, H20), 7.46 (1H, dd, J = 2.0,
8.4 Hz, H60), 6.95 (1H, d, J = 8.4 Hz, H50), 6.54 (1H, s, H3), 6.31 (1H,
s, H6), 8-C-b-Glu 5.06 (1H, d, J = 10.1 Hz, H100), 4.08 (1H, t,
J = 9.1 Hz, H200), 3.95 (1H, dd, J = 2.4, 12.1 Hz, H6a00), 3.85 (1H, dd,
J = 5.2, 11.9 Hz, H6b00), 3.67 (1H, t, J = 9.0 Hz, H400), 3.58 (1H, t,
J = 8.9 Hz, H300), 3.54 (1H, m, H500). 13C NMR (125 MHz, d4-MeOD,
350 K) 182.5 (C4), 165.1 (C2), 163.1 (C7), 161.5 (C5), 156.4 (C9),
148.8 (C40), 145.6 (C30), 122.9 (C10), 119.5 (C60), 115.5 (C50), 113.6
(C20), 104.4 (C10), 103.2 (C8), 102.8 (C3), 99.0 (C6), 81.3 (C500),
79.0 (C300), 74.7 (C100), 71.9 (C200), 70.6 (C400), 61.7 (C600).
ESIMS m/z (CV = 50, rel. int.): 493 [MH+46 (formic acid)] (100),
447 [MH] (17); ESIMS m/z (CV = 150, rel. int.): 493 [MH+46]
(14), 447 [MH] (3), 403 [MH+46-90] (9), 373 [MH+46-
120] (10), 357 [MH90] (12), 327 [MH120] (98).
4.2.4. 6-C-Glucosylluteolin (isoorientin) 6b
UV (kmax MeOH/H2O) 298, 352 nm. 1H NMR (500 MHz,
d4-MeOD, 350 K) d 7.40 (1H, d, J = 2.1 Hz, H20), 7.38 (1H, dd,
J = 2.2, 8.3 Hz, H60), 6.94 (1H, d, J = 8.3 Hz, H50), 6.55 (1H, s, H3),
6.52 (1H, s, H8), 6-C-b-Glu 4.96 (1H, d, J = 9.9 Hz, H100), 4.08 (1H,
dd, J = 8.8, 9.6 Hz, H200), 3.89 (1H, dd, J = 2.7, 12.0, H6a00), 3.79
(1H, dd, J = 5.0, 12.0 Hz, H6b00), 3.55 (1H, t, J = 8.4 Hz, H400), 3.52
(1H, t, J = 8.7 Hz, H300), 3.46 (1H, ddd, J = 2.6, 4.9, 9.3 Hz, H500). 13C
NMR (125 MHz, d4-MeOD, 350 K) 182.4 (C4), 164.8 (C2), 163.0
(C7), 160.5 (C5), 157.4 (C9), 149.0 (C40), 145.6 (C30), 122.6 (C10),
119.0 (C60), 115.5 (C50), 113.1 (C20), 107.8 (C6), 104.0 (C10), 102.9
(C3), 94.1 (C8), 80.9 (C500), 78.7 (C300), 74.1 (C100), 71.7 (C200), 70.4
(C400), 61.5 (C600). ESIMS m/z (CV = 50, rel. int.): 447 [MH]
(100); ESIMS m/z (CV = 150, rel. int.): 447 [MH] (16), 357
[MH90] (33), 327 [MH120] (72).
4.2.5. 30-O-Methyl-8-C-glucosylluteolin 5d
UV (kmax MeOH/H2O) 269, 348 nm. 1H NMR (500 MHz,
d4-MeOD, 350 K) d 7.49 (1H, br d, J = 8.3 Hz, H60), 7.56 (1H, br s,
H20), 6.98 (1H, br d, J = 7.3 Hz, H50), 6.61 (1H, s, H3), 6.30 (1H, s,
H6), 4.01 (3H, s, OMe), 8-C-b-Glu 5.09 (1H, d, J = 9.1 Hz, H100),
4.09 (1H, br s, H200), 3.93 (1H, br d, J = 11.9 Hz, H6a00), 3.80 (1H, br
m, H6b00), 3.62 (1H, br t, J = 11.0 Hz, H400), 3.55 (1H, br t,
J = 7.2 Hz, H300), 3.51 (1H, m, H500). 13C NMR (125 MHz, d4-MeOD,
350 K, partial characterisation) 120.9 (C60), 115.5 (C50), 110.5
(C20), 103.0 (C3), 99.3 (C6), 81.5 (C500), 79.0 (C300), 74.8 (C100), 71.8
(C200), 70.6 (C400), 61.5 (C600), 56.0 (OMe).). ESIMS m/z (CV = 50, rel.
int.): 507 [MH+46 (formic acid)] (20), 461 [MH] (100); ESIMS
m/z (CV = 150, rel. int.): 461 [MH] (5), 371 [MH90] (2), 341
[MH120] (20).
4.2.6. 30-O-Methyl-6-C-glucosylluteolin 6d
UV (kmax MeOH/H2O) 272, 352 nm. 1H NMR (500 MHz,
d4-MeOD, 330 K) d 7.49 (1H, br d, J = 8.6 Hz, H60), 7.46 (1H, br s,
H20), 6.95 (1H, d, J = 8.2 Hz, H50), 6.60 (1H, s, H3), 6.51 (1H, s,
H8), 3.97 (3H, c, OMe), 6-C-b-Glu 4.95 (1H, d, J = 9.8 Hz, H100),
4.12 (1H, t, J = 8.8 Hz, H200), 3.90 (1H, br d, J = 11.7, H6a00), 3.79
(1H, dd, J = 4.7, 11.9 Hz, H6b00), 3.55–3.50 (2H, m, H300, H400), 3.46
(1H, br m, H500). 13C NMR (125 MHz, d4-MeOD, 330 K) 182.2 (C4),
164.7 (C2), 162.7 (C7), 160.4 (C5), 156.9 (C9), 150.2 (C40), 148.1
(C30), 122.1 (C10), 121.5 (C60), 116.6 (C50), 110.8 (C20), 107.7 (C6),
104.1 (C3), 103.6 (C10), 95.2 (C8), 82.2 (C500), 79.9 (C300), 75.2
(C100), 72.7 (C200), 71.6 (C400), 62.6 (C600). ESIMS m/z (CV = 50, rel.
int.): 461 [MH] (100); ESIMS m/z (CV = 150, rel. int.): 461
[MH] (8), 371 [MH90] (9), 341 [MH120] (20).
4.2.7. 40-O-Methylvitexin 5f
UV (kmax MeOH/H2O) 273, 333 nm. 1H NMR (500 MHz,
d4-MeOD, 345 K) d 7.97 (2H, d, J = 8.3 Hz, H20, H60), 7.06 (2H, d,
J = 8.7 Hz, H30, H50), 6.58 (1H, s, H3), 6.27 (1H, s, H6), 3.87 (3H, s,
Me), 8-C-b-Glu 5.02 (1H, d, J = 9.7 Hz, H100), 4.05 (1H, br t,
J = 8.8 Hz, H200), 3.92 (1H, br d, J = 11.6 Hz, H6a00), 3.80 (1H, dd,
J = 5.1, 12.0 Hz, H6b00), 3.63 (1H, br t, J = 8.8 Hz, H400), 3.55 (1H, t,
J = 8.8 Hz, H300), 3.50 (1H, m, H500). 13C NMR (125 MHz, d4-MeOD,
345 K) 181.3 (C4), 163.8 (C2), 162.2 (C7), 161.9 (C40), 160.3 (C5),
155.4 (C9), 127.4 (C20, C60), 122.6 (C10), 113.4 (C30, C50), 104.0
(C10), 102.7 (C8), 102.2 (C3), 98.1 (C6), 80.6 (C500), 78.1 (C300),
73.7 (C100), 70.9 (C200), 69.9 (C400), 60.7 (C600), 53.8 (OMe).
ESIMS m/z (CV = 50, rel. int.): 445 [MH] (100); ESIMS m/z
(CV = 150, rel. int.): 445 [MH] (7), 355 [MH90] (3), 325
[MH120] (55).
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4.2.8. 40-O-Methyiisovitexin 6f
UV (kmax MeOH/H2O) 271, 334 nm. 1H NMR (500 MHz,
d4-MeOD, 345 K) d 7.88 (2H, d, J = 8.6 Hz, H20, H60), 7.06 (2H, d,
J = 8.6 Hz, H30, H50), 6.58 (1H, s, H3), 6.50 (1H, s, H8), 3.87 (3H, s,
Me), 6-C-b-Glu 4.93 (1H, d, J = 10.0 Hz, H100), 4.07 (1H, t,
J = 8.9 Hz, H200), 3.87 (1H, obsc., H6a00), 3.76 (1H, dd, J = 4.7,
12.0 Hz, H6b00), 3.52–3.49 (2H, m, H300, H400), 3.44 (1H, m, H500).
13C NMR (125 MHz, d4-MeOD, 345 K) 181.3 (C4), 163.3 (C2),
162.6 (C40), 162.3 (C7), 160.2 (C5), 156.8 (C9), 127.8 (C20, C60),
121.4 (C10), 114.3 (C30, C50), 107.9 (C6), 103.2 (C3), 102.5 (C10),
94.1 (C8), 81.0 (C500), 78.7 (C300), 74.1 (C100), 71.6 (C200), 70.4 (C400),
61.4 (C600), 54.6 (OMe). ESIMS m/z (CV = 50, rel. int.): 445 [MH]
(100); ESIMS m/z (CV = 150, rel. int.): 445 [MH] (7), 355
[MH90] (21), 325 [MH120] (52).
4.2.9. 8-C-Glucosylchrysin 5g
UV (kmax MeOH/H2O) 269, 315 nm. 1H NMR (500 MHz,
d4-MeOD, 345 K) d 8.03 (2H, br d, J = 6.4 Hz, H20, H60), 7.55–7.53
(3H, m, H30, H40, H50), 6.70 (1H, s, H3), 6.30 (1H, s, H6), 8-C-b-Glu
5.04 (1H, d, J = 8.4 Hz, H100), 4.06 (1H, t, J = 9.3 Hz, H200), 3.91 (1H,
d, J = 12.4 Hz, H6a00), 3.79 (1H, dd, J = 4.8, 12.5 Hz, H6b00), 3.61
(1H, t, J = 9.5 Hz, H400), 3.54 (1H, t, J = 8.9 Hz, H300), 3.50 (1H, m,
H500). 13C NMR (125 MHz, d4-MeOD, 345 K) 182.0 (C4), 164.3
(C2), 163.0 (C7), 161.3 (C5), 156.4 (C9), 131.4 (C40), 131.1 (C10),
128.5 (C30, C50), 126.4 (C20, C60), 104.7 (C3), 104.3 (C10), 103.1
(C8), 99.1 (C6), 81.3 (C500), 78.9 (C300), 74.6 (C100), 71.8 (C200), 70.7
(C400), 61.6 (C600). ESIMS m/z (CV 50, rel. int.): 415 [MH] (100);
ESIMS m/z (CV = 150, rel. int.): 415 [MH] (2), 325 [MH90]
(2), 295 [MH120] (25).
4.2.10. 6-C-Glucosylchrysin 6g
UV (kmaxMeOH/H2O) 271, 317 nm. 1HNMR (500 MHz, d4-MeOD,
330 K) d 7.93 (2H, br d, J = 9.0 Hz, H20, H60), 7.56–7.53 (3H, m, H30,
H40, H50), 6.70 (1H, s, H3), 6.52 (1H, s, H8), 8-C-b-Glu 4.92 (1H, d,
J = 9.8 Hz, H100), 4.11 (1H, t, J = 8.8 Hz, H200), 3.87 (1H, d, J = 11.9 Hz,
H6a00), 3.74 (1H, dd, J = 4.4, 11.9 Hz, H6b00), 3.52–3.48 (2H, m, H300,
H400), 3.44 (1H, m, H500). 13C NMR (125 MHz, d4-MeOD, 330 K)
182.5 (C4), 164.4 (C2), 163.6 (C7), 160.1 (C5), 156.6 (C9), 131.5
(C40), 130.1 (C10), 128.8 (C30, C50), 125.9 (C20, C60), 108.0 (C8),
104.8 (C3), 103.6 (C10), 94.2 (C6), 81.1 (C500), 78.7 (C300), 74.0
(C100), 71.4 (C200), 70.4 (C400), 61.5 (C600). ESIMS m/z (CV = 50, rel.
int.): 415 [MH] (100); ESIMSm/z (CV = 150, rel. int.): 415 [MH]
(1), 325 [MH90] (5), 295 [MH120] (20).
4.2.11. 30-40-Methylenedioxy-8-C-glucosylchrysin 5h
UV (kmax MeOH/H2O) 271, 348 nm. 1H NMR (500 MHz,
d4-MeOD, 330 K) d 7.66 (1H, d, J = 8.0 Hz, H60), 7.55 (1H, s, H20),
6.99 (1H, d, J = 8.2 Hz, H50), 6.59 (1H, s, H3), 6.28 (1H, s, H6), 6.08
(2H, s, OCH2O), 8-C-b-Glu 5.04 (1H, d, J = 9.5 Hz, H100), 4.08 (1H, t,
J = 9.3 Hz, H200), 3.96 (1H, br d, J = 11.1 Hz, H6a00), 3.82 (1H, dd,
J = 5.5, 11.9 Hz, H6b00), 3.64 (1H, t, J = 9.1 Hz, H400), 3.56 (1H, t,
J = 8.8 Hz, H300), 3.54 (1H, m, H500). 13C NMR (125 MHz, d4-MeOD,
330 K) 181.6 (C4), 164.2 (C7), 163.4 (C2), 160.1 (C5), 156.2 (C9),
150.6 (C40), 148.4 (C30), 124.9 (C10), 121.9 (C60), 108.2 (C50), 106.3
(C20), 103.8 (C10), 103.2 (C8), 103.3 (C3), 102.0 (OCH2O), 99.2
(C6), 81.4 (C500), 79.0 (C300), 74.4 (C100), 71.7 (C200), 70.7 (C400), 61.7
(C600). ESIMS m/z (CV = 50, rel. int.): 459 [MH] (100); ESIMS
m/z (CV = 150, rel. int.): 459 [MH] (18), 369 [MH90] (7),
339 [MH120] (100).
4.2.12. 30-40-Methylenedioxy-6-C-glucosylchrysin 6h
UV (kmax MeOH/H2O) 270, 348 nm. 1H NMR (500 MHz,
d4-MeOD, 330 K) d 7.52 (1H, d, J = 8.1 Hz, H60), 7.38 (1H, s, H20),
6.95 (1H, d, J = 8.1 Hz, H50), 6.58 (1H, s, H3), 6.50 (1H, s, H8), 6.05
(2H, s, OCH2O), 6-C-b-Glu 4.91 (1H, d, J = 9.8 Hz, H100), 4.10 (1H, t,
J = 8.8 Hz, H200), 3.86 (1H, br d, J = 11.8 Hz, H6a00), 3.75 (1H, dd,
J = 4.8, 11.8 Hz, H6b00), 3.51–3.48 (2H, m, H300, H400), 3.43 (1H, m,
H500). 13C NMR (125 MHz, d4-MeOD, 330 K) 182.3 (C4), 164.1
(C2), 163.3 (C7), 160.4 (C5), 156.9 (C9), 150.7 (C40), 148.8 (C30),
124.9 (C10), 121.4 (C60), 108.1 (C50), 108.0 (C6), 105.7 (C20), 103.8
(C10), 103.5 (C3), 93.9 (C8), 81.0 (C500), 78.6 (C300), 73.9 (C100),
71.3 (C200), 70.3 (C400), 61.3 (C600). ESIMS m/z (CV = 50, rel. int.):
459 [MH] (100); ESIMS m/z (CV = 150, rel. int.): 459 [MH]
(12), 369 [MH90] (35), 339 [MH120] (100).
4.2.13. 40-Methyl-8-C-glucosylchrysin 5o
UV (kmax MeOH/H2O) 270, 317 nm. 1H NMR (500 MHz,
d4-MeOD, 325 K) d 7.97 (2H, br s, H20,H60), 7.39 (2H, br d,
J = 8.0 Hz, H30, H50), 6.69 (1H, s, H3), 6.31 (1H, s, H6), 8-C-b-Glu
5.05 (1H, d, J = 9.1 Hz, H100), 4.11 (1H, t, J = 8.7 Hz, H200), 3.96 (1H,
br d, J = 11.4, H6a00), 3.81 (1H, dd, J = 5.5, 12.0 Hz, H6b00), 3.65 (1H,
m, H400), 3.56 (1H, t, J = 8.8 Hz, H300), 3.52 (1H, m, H500), 2.44 (3H,
s, Me). 13C NMR (125 MHz, d4-MeOD, 325 K) 182.6 (C4), 164.6
(C2), 162.5 (C7), 161.5 (C5), 156.7 (C9), 142.6 (C40), 129.4 (C30,
C50), 128.2 (C10), 126.4 (C20, C60), 104.3 (C10), 103.8 (C3), 102.7
(C8), 98.7 (C6), 81.4 (C500), 78.9 (C300), 74.1 (C100), 71.6 (C200), 70.7
(C400), 61.7 (C600). ESIMS m/z (CV = 50, rel. int.): 429 [MH]
(100); ESIMS m/z (CV = 150, rel. int.): 429 [MH] (1), 339
[MH90] (2), 309 [MH120] (22).
4.2.14. 40-Methyl-6-C-glucosylchrysin 6o
UV (kmaxMeOH/H2O) 272, 321 nm. 1HNMR (500 MHz, d4-MeOD,
325 K) d 7.87 (2H, d, J = 8.0 Hz, H20, H60), 7.38 (2H, d, J = 7.8 Hz, H30,
H50), 6.70 (1H, s, H3), 6.55 (1H, s, H8), 6-C-b-Glu 4.95 (1H, d,
J = 9.7 Hz, H100), 4.14 (1H, t, J = 8.7 Hz, H200), 3.89 (1H, br d, J = 11.6,
H6a00), 3.78 (1H, dd, J = 4.7, 11.8 Hz, H6b00), 3.55–3.49 (2H, m, H300,
H400), 3.46 (1H, m, H500), 2.45 (3H, s, Me). 13C NMR (125 MHz, d4-
MeOD, 325 K) 182.2 (C4), 164.4 (C2), 163.4 (C7), 160.4 (C5), 157.3
(C9), 142.8 (C40), 129.4 (C30, C50), 127.9 (C10), 125.9 (C20, C60),
107.8 (C6), 103.9 (C10), 104.1 (C3), 94.0 (C8), 81.1 (C500), 78.7
(C300), 74.0 (C100), 71.4 (C200), 70.3 (C400), 61.5 (C600). ESIMS m/z
(CV = 50, rel. int.): 429 [MH] (100); ESIMS m/z (CV = 150, rel.
int.): 429 [MH] (1), 339 [MH90] (6), 309 [MH120] (23).
4.2.15. 40-EthyI-8-C-glucosylchrysin 5p
UV (kmax MeOH/H2O) 272, 317 nm. 1H NMR (500 MHz,
d4-MeOD, 350 K) d 7.94 (2H, d, J = 7.8 Hz, H20, H60), 7.37 (2H, d,
J = 7.9 Hz, H30, H50), 6.65 (1H, s, H3), 6.29 (1H, s, H6), 2.72 (2H. q,
J = 7.6 Hz, Et), 1.26 (3H, t, J = 7.5 Hz, Et), 6-C-b-Glu 5.04 (1H, d,
J = 9.6 Hz, H100), 4.07 (1H, br t, J = 8.6 Hz, H200), 3.92 (1H, br d,
J = 11.9 Hz, H6a00), 3.79 (1H, dd, J = 5.0, 12.1 Hz, H6b00), 3.63 (1H, t,
J = 9.0 Hz, H400), 3.54 (1H, t, J = 8.8 Hz, H300), 3.50 (1H, m, H500). 13C
NMR (125 MHz, d4-MeOD, 350 K) 182.3 (C4), 164.7 (C2), 163.3
(C7), 161.3 (C5), 156.4 (C9), 148 7 (C40), 128.2 (C30, C50), 126.5
(C20, C60), 122.6 (C10), 104.4 (C10), 104.0 (C3), 103.4 (C8), 99.0
(C6), 81.3 (C500), 79.0 (C300), 74.4 (C100), 71.8 (C200), 70.8 (C400), 61.6
(C600), 28.2 (CH2), 13.9 (CH3). ESIMS m/z (CV = 50, rel. int.): 443
[MH] (100); ESIMS m/z (CV = 150, rel. int.): 443 [MH] (1),
353 [MH90] (2), 323 [MH120] (34).
4.2.16. 40-EthyI-6-C-glucosylchrysin 6p
UV (kmax MeOH/H2O) 272, 317 nm. 1H NMR (500 MHz,
d4-MeOD, 340 K) d 7.83 (2H, d, J = 7.6 Hz, H20, H60), 7.36 (2H, d,
J = 7.5 Hz, H30, H50), 6.64 (1H, s, H3), 6.50 (1H, s, H8), 2.72 (2H. q,
J = 7.5 Hz, Et), 1.26 (3H, t, J = 7.5 Hz, Et), 6-C-b-Glu 4.93 (1H, d,
J = 9.8 Hz, H100), 4.08 (1H, t, J = 8.8 Hz, H200), 3.87 (1H, br d,
J = 11.8 Hz, H6a00), 3.76 (1H, dd, J = 4.0, 11.9 Hz, H6b00), 3.54–3.48
(2H, m, H300, H400), 3.44 (1H, m, H500). 13C NMR (125 MHz, d4-MeOD,
340 K) 182.2 (C4), 164.3 (C2), 163.3 (C7), 160.2 (C5), 157.3 (C9),
148 8 (C40), 128.2 (C30, C50), 126.0 (C20, C60), 121.2 (C10), 108.0
(C6), 104.2 (C3), 104.0 (C10), 94.2 (C8), 81.0 (C500), 78.7 (C300),
74.1 (C100), 71.6 (C200), 70.4 (C400), 61.4 (C600), 28.2 (CH2), 13.9
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(CH3). ESIMS m/z (CV = 50, rel. int.): 443 [MH] (100); ESIMSm/z
(CV = 150, rel. int.): 433 [MH] (1), 353 [MH90] (2), 313
[MH120] (36).
4.2.17. 30-Fluorovitexin 5r
UV (kmax MeOH/H2O) 269, 327 nm. 1H NMR (500 MHz,
d4-MeOD, 325 K) d 7.77 (1H, d, J = 13.0 Hz, H20), 7.70 (1H, d,
J = 8.7 Hz, H60), 7.01 (1H, t, J = 8.7 Hz, H50), 6.56 (1H, s, H3), 6.26
(1H, s, H6), 6-C-b-Glu 5.05 (1H, d, J = 9.9 Hz, H100), 4.10 (1H, t,
J = 9.4 Hz, H200), 3.96 (1H, br d, J = 10.8, H6a00), 3.82 (1H, dd,
J = 5.8, 12.1 Hz, H6b00), 3.65 (1H, t, J = 9.3 Hz, H400), 3.56 (1H, t,
J = 8.8 Hz, H300), 3.54 (1H, m, H500). 13C NMR (125 MHz, d4-MeOD,
325 K) 181.7 (C4), 163.8 (C2), 163.6 (C7), 161.2 (C5), 156.4 (C9),
151.4 (d, J = 151.4 Hz, C30), 151.3 (C400), 123.5 (C60), 120.4 (C10),
118.7 (C50), 114.0 (C20), 103.9 (C8), 103.5 (C10), 102.4 (C3), 99.3
(C6), 81.4 (C500), 79.0 (C300), 74.5 (C100), 71.7 (C200), 71.0 (C400), 61.9
(C600). ESIMS m/z (CV = 150, rel. int.): 449 [MH] (12), 359
[MH90] (10), 329 [MH120] (100).
4.2.18. 30-Fluoroisovitexin 6r
UV (kmax MeOH/H2O) 271, 332 nm. 1H NMR (500 MHz,
d4-MeOD, 310 K) d 7.69 (1H, dd, J = 1.7, 12.2 Hz, H20), 7.65 (1H, br
d, J = 8.7 Hz, H60), 7.04 (1H, t, J = 8.6 Hz, H50), 6.61 (1H, s, H3),
6.52 (1H, s, H8), 6-C-b-Glu 4.93 (1H, d, J = 9.9 Hz, H100), 4.18 (1H,
t, J = 9.1 Hz, H200), 3.90 (1H, dd, J = 2.0, 12.0, H6a00), 3.78 (1H, dd,
J = 5.1, 12.1 Hz, H6b00), 3.54–3.49 (2H, m, H300, H400), 3.45 (1H, m,
H500). 13C NMR (125 MHz, d4-MeOD, 310 K) 182.0 (C4), 164.1
(C7), 163.2 (C2), 160.4 (C5), 156.8 (C9), 152.3 (d, J = 230.0 Hz,
C30), 151.3 (C400), 123.1 (C60), 121.4 (C10), 118.2 (C50), 113.6 (C20),
107.8 (C6), 103.6 (C10), 102.9 (C3), 94.0 (C6), 81.2 (C500), 78.8
(C300), 74.0 (C100), 71.3 (C200), 70.4 (C400), 61.5 (C600). ESIMS m/z
(CV = 150, rel. int.): 449 [MH] (17), 359 [MH90] (57), 329
[MH120] (100).
4.2.19. 40-Fluoro-8-C-glucosylchrysin 5t
UV (kmaxMeOH/H2O) 269, 316 nm. 1HNMR (500 MHz, d4-MeOD,
325 K) d 8.17 (2H, br t, J = 6.6 Hz, H20, H60), 7.32 (2H, t, J = 8.7 Hz, H30,
H50), 6.72 (1H, s, H3), 6.32 (1H, s, H6), 6-C-b-Glu 5.06 (1H, d,
J = 10.0 Hz, H100), 4.10 (1H, t, J = 9.3 Hz, H200), 3.96 (1H, dd, J = 2.0,
12.1, H6a00), 3.85 (1H, dd, J = 5.1, 12.0 Hz, H6b00), 3.67 (1H, br t,
9.4 Hz, H400), 3.57 (1H, t, J = 8.8 Hz, H300), 3.52 (1H, m, H500). 13C
NMR (125 MHz, d4-MeOD, 325 K) 182.6 (C4), 165.0 (d, J = 250 Hz,
C40), 164.0 (C5), 163.5 (C7), 163.5 (C2), 156.7 (C9), 129.2 (d,
J = 8.8 Hz, C20, C60), 128.0 (C10), 115.7 (d, J = 22.5 Hz, C30, C50),
104.4 (C10), 104.4 (C3), 104.2 (C8), 98.9 (C6), 81.4 (C500), 78.9
(C300), 74.5 (C100), 71.6 (C200), 70.2 (C400), 61.4 (C600). 19F NMR
(470 MHz, d4-MeOD, 325 K)at 109.9. ESIMS m/z (CV = 150, rel.
int.): 433 [MH] (15), 343 [MH90] (7), 313 [MH120]
(100).
4.2.20. 40-Fluoro-6-C-glucosylchrysin 6t
UV (kmax MeOH/H2O) 271, 317 nm. 1H NMR (500 MHz,
d4-MeOD, 325 K) d 8.01 (2H, dd, J = 5.2, 8.9 Hz, H20, H60), 7.27
(2H, t, J = 8.7 Hz, H30, H50), 6.69 (1H, s, H3), 6.52 (1H, s, H6), 6-C-
b-Glu 4.92 (1H, d, J = 9.9 Hz, H100), 4.11 (1H, t, J = 8.8 Hz, H200),
3.86 (1H, dd, J = 2.2, 12.0, H6a00), 3.75 (1H, dd, J = 5.1, 12.2 Hz,
H6b00), 3.52–3.46 (2H, m, H300, H400), 3.44 (1H, m, H500). 13C NMR
(125 MHz, d4-MeOD, 325 K) 182.8 (C4), 165.3 (d, J = 247.5 Hz,
C40), 163.5 (C7), 163.5 (C2), 160.9 (C5), 157.8 (C9), 128.5 (d,
J = 10.0 Hz, C20, C60), 127.8 (C10), 115.8 (d, J = 22.5 Hz, C30, C50),
108.3 (C6), 104.8 (C10), 104.6 (C3), 94.1 (C8), 81.1 (C500), 78.8
(C300), 74.0 (C100), 71.4 (C200), 70.4 (C400), 61.4 (C600). 19F NMR
(470 MHz, d4-MeOD, 325 K)at 110.5 (dt, J = 8.3 5.7 Hz). ESIMS
m/z (CV = 150, rel. int.): 433 [MH] (15), 343 [MH90] (20),
313 [MH120] (100).
4.3. Generation of 6-C-2-hydroxyglucosylflavanones from 3 using
recombinant OsCGT
A His-tagged OsCGT gene from rice (a gift from R Edwards,
Newcastle University) was transformed into E. coli strain BL21
(NEB). Cultures were grown in LB broth containing 50 lg/ml
kanamycin at 30 C and shaken at 200 rpm. At OD 600 nm 0.6–1,
protein expression was induced by addition of 1 mM isopropyl-
1-thio-b-D-galactopyranoside (IPTG) and carried out for four hours.
The OsCGT protein was purified according to precedent (Liu et al.,
2002), with the following modifications; Tris buffer was substi-
tuted with 50 mM NaH2PO4 at pH 8. Cell lysis by sonication was
performed in 50 mMNaH2PO at pH 8, 300 mMNaCl, 10 mM imida-
zole, 1 mM benzamidine, 0.1 mM phenylmethanesulfonyl fluoride
(PMSF) and 2 mM dithiothreitol (DTT). Purified protein was con-
centrated by centrifugation using 30 KDa cut-off columns (Vivas-
pin) and re-suspended in 50 mM HEPES buffer at pH 8. Protein
was concentrated to approximately 1 mg/ml before being snap fro-
zen in 0.2 ml aliquots and stored at 80 C. 2-Hydroxyflavanone 3
(40 lL of a 20 mmol solution) in ethanol was added to 1 mg of
UDP-glucose dissolved in 40 lL buffer with 50 lg recombinant
OsCGT (Hamilton et al., 2012) dissolved in 200 ll 100 mM HEPES
pH 7.5 buffer and incubated at 30 C overnight. The assay was
quenched with ice cold MeOH (250 lL) to precipitate protein
which was removed by centrifugation at 4 C. 1.5 assay equivalents
of the crude C-glucosyl-2-hydroxyflavanone was then used directly
in a single subsequent D. incanum enzyme assay.
4.4. D. incanum soluble root protein
Roots of D. incanum were snap frozen in liquid nitrogen and
blended in ice cold 5 v/w 100 mM HEPES pH 7.2, 2 mM DTT, 2.5%
PVP, 0.5 mM EDTA, 1 mM benzamidine, 0.1 mM PMSF. Protein
was precipitated between 40% and 80% (NH4)2SO4 and the pellet
recovered by centrifugation. The protein pellets were desalted in
20 mM HEPES-NaOH pH 8 containing 2 mM DTT using Sephadex
G-25 gel filtration chromatography (PD-10 columns, GE Health-
care) and the desalted solution concentrated by centrifugation
using 30 KDa cut-off columns (Vivaspin) for assays.
4.5. Mono-C-glycosylflavone biosynthesis assays with D. incanum root
proteins
D. incanum root protein (1 g equivalent as obtained in 4.4) was
added to 2-hydroxyflavanone 3 (40 lL of a 20 mmol solution in
ethanol) with 1 mg of UDP-glucose dissolved in 40 lL buffer
(100 mM HEPES, 2 mM DTT, pH 7.5) and the solution made up to
400 ll with more buffer. The assay was incubated at 30 C over-
night and quenched with 1 M HCl. The solution was cleared by cen-
trifugation and the supernatant decanted, dried under a stream of
nitrogen and dissolved in MeOH (250 lL) for LCMS analysis.
4.6. Di-C-glycosylflavone biosynthesis assays with D. incanum root
proteins
D. incanum root protein (1 g equivalent as obtained in 4.4) was
added to the 6-glucosyl-2-hydroxyflavanone substrate 4 from 4.3
(1.5 assay equivalents dissolved in buffer) with 1 mg of UDP-glu-
cose dissolved in 40 lL buffer (100 mM HEPES, 2 mM DTT, pH
7.5) and the solution made up to 400 ll with more buffer. The
assay was incubated at 30 C overnight and quenched with 1 M
HCl. In the case of assays with UDP-arabinose they were conducted
with 0.1 mg UDP-arabinose due to the cost and availability of the
sugar donor. In the case of substrate 4b, the entire assay was car-
ried out on 1/10th scale using UDP-a-D-[UL-13C6]glucose. All assays
were quenched 1 M HCl (250 ll), centrifuged and decanted.
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The resulting solution was evaporated under a stream of nitrogen
and the residue re-dissolved in MeOH (250 ll) for LCMS analysis.
4.7. HPLC analysis of OsCGT enzyme assays
The residue from a single enzyme assay was dissolved in 500 lL
3:1 H2O/MeOH for HPLC analysis on a Shimadzu VP series HPLC
system using an ACEQ C-18 column (250 mm  4.6 mm, 5 lm).
The mobile phase used a gradient program at 1 mL/min, initially
95:5 (A:B), to 85:15 at 3 min, 75:25 at 13 min, 70:30 at 25 min,
45:55 at 35 min, 45:55 at 45 min, 5:95 at 46 min, 5:95 at 58 min,
95:5 at 60 min (Ferreres et al., 2003).
4.8. LCMS analysis of exudates
The enzyme assay products were subject to LCMS either as they
were or diluted tenfold in MeOH. The mass spectrometer was oper-
ated in negative ion mode, with a capillary voltage of 2.7 kV, cone
voltage 50–180 eV, mass range 50–1000m/z. Source temperature
130 C, desolvation temperature 350 C, desolvation gas flow
1000 L/h (nitrogen) and cone gas flow 60 L/h (nitrogen). Where
required, selected ions were admitted to the collision cell for
MSMS analysis with argon admitted at a pressure of 2.1 e3 mbar,
causing CID. Samples were injected via the Acquity sample man-
ager, injecting 2 ll onto an Acquity UPLC BEC HSS C18 1.8 lm
2.1  150 mm column. Run time was 42 min at a flow rate of
0.21 mL/min. Solvents used are defined A (water, 0.05% formic
acid) and B (methanol). The mobile phase used a gradient program,
initially 95:5 (A:B), to 85:15 at 1.8 min, 75:25 at 7.7 min, 70:30 at
17.9 min, 45:55 at 23.8 min, 45:55 at 26.8 min, 5:95 at 30.4 min,
5:95 at 37.5 min, 95:5 at 38.7 min, 95:5 at 40 min. Standards for
comparison were obtained previously from Desmodium plant tis-
sue and fully characterised by NMR spectroscopy (Hooper et al.,
2015).
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